牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

近岸蛋白（688137）

4.0

综合诊断：4.0分打败了9%的股票！

卖出
减持
中性
增持
买入

短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
中期趋势：
-
长期趋势：
已有24家主力机构披露2024-06-30报告期持股数据，持仓量总计1608.76万股，占流通A股50.10%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

1.4分

6.5分

5.5分

4.3分

4.2分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：1.4技术面打败了3%的股票技术面评分前10的股票

近期的平均成本为37.03元。

技术面得分最高的股票

平均成本

近期的平均成本为37.03元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"37.03","date":1733130122,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势明显跑输大盘，明显跑输行业平均水平。

[{"date":"2024.12.03","stock":"-55.21","trade":"0.20","ind":"0.44"},{"date":"2024.12.02","stock":"-56.75","trade":"1.87","ind":"1.13"},{"date":"2024.11.29","stock":"-55.12","trade":"1.22","ind":"0.93"},{"date":"2024.11.28","stock":"-56.95","trade":"-0.42","ind":"-0.43"},{"date":"2024.11.27","stock":"-54.91","trade":"1.94","ind":"1.53"},{"date":"2024.11.26","stock":"-57.28","trade":"-0.20","ind":"-0.12"},{"date":"2024.11.25","stock":"-56.91","trade":"1.10","ind":"-0.10"},{"date":"2024.11.22","stock":"-57.36","trade":"-4.70","ind":"-3.06"},{"date":"2024.11.21","stock":false,"trade":"0.22","ind":"0.07"},{"date":"2024.11.20","stock":false,"trade":"2.52","ind":"0.66"},{"date":"2024.11.19","stock":false,"trade":"2.19","ind":"0.67"},{"date":"2024.11.18","stock":false,"trade":"-2.07","ind":"-0.21"},{"date":"2024.11.15","stock":false,"trade":"-2.51","ind":"-1.45"},{"date":"2024.11.14","stock":false,"trade":"-3.03","ind":"-1.73"},{"date":"2024.11.13","stock":false,"trade":"-1.31","ind":"0.51"},{"date":"2024.11.12","stock":false,"trade":"0.55","ind":"-1.39"},{"date":"2024.11.11","stock":false,"trade":"2.28","ind":"0.51"},{"date":"2024.11.08","stock":false,"trade":"-0.32","ind":"-0.53"},{"date":"2024.11.07","stock":false,"trade":"2.56","ind":"2.57"},{"date":"2024.11.06","stock":false,"trade":"-0.13","ind":"-0.09"},{"date":"2024.11.05","stock":false,"trade":"2.58","ind":"2.32"}]

近岸蛋白,上证指数,生物制品指数

压力支撑

该股压力位为36.93元，支撑位为36.39元。

[{"text":"\u538b\u529b\u4f4d","value":"36.93","date":1733155200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"36.39","date":1733155200,"color":"0x0b52a1"}]

多空趋势

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：6.5资金面打败了87%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力集中了一定的筹码，呈中度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

生物制品行业，近5日资金总体无进出。

更新时间：12月03日 20:31

机构今日流向(万元)	-495.20	机构5日流向(万元)	1017.71
机构10日流向(万元)	-4976.13	机构20日流向(万元)	-13617.59

机构持仓

2024-06-30 与 2023-12-31 相比，主力机构持仓量增加32.35万股，其中基金净增仓2家，主力净减仓42家，请投资者中长期谨慎为宜。

截止2024-06-30，共24家主力机构（基金17家，一般法人7家），持仓量总计1608.76万股，占流通A股50.10%
其中，基金持仓与2023-12-31相比：
增仓：4家，增持 16.47万股
减仓：2家，减持 38.75万股
新出现在主力名单中：5家，持有220.89万股
从主力名单中消失：47家，原持有166.26万股

消息面诊股

诊断结果：5.5消息面打败了81%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	临时股东大会	2024-09-28
一般消息	募资投向		2024-09-26
一般消息	分红转增	不分配不转增	2024-08-30
利空	重大事项	公司违规：处罚类型	2024-07-09
利好	分红转增	10派5元(含税)	2024-04-29
重大利空	业绩预告	业绩大幅下降	2024-01-31

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	2条	1条	1条

行业面诊股

诊断结果：4.3行业面打败了39%的股票生物制品行业最新资金流向

近10日来该行业走势不明显，明显跑赢大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑赢大盘。

[{"date":"2024.12.03","price":"0.44","value":"0.20"},{"date":"2024.12.02","price":"1.13","value":"1.87"},{"date":"2024.11.29","price":"0.93","value":"1.22"},{"date":"2024.11.28","price":"-0.43","value":"-0.42"},{"date":"2024.11.27","price":"1.53","value":"1.94"},{"date":"2024.11.26","price":"-0.12","value":"-0.20"},{"date":"2024.11.25","price":"-0.10","value":"1.10"},{"date":"2024.11.22","price":"-3.06","value":"-4.70"},{"date":"2024.11.21","price":"0.07","value":"0.22"},{"date":"2024.11.20","price":"0.66","value":"2.52"},{"date":"2024.11.19","price":"0.67","value":"2.19"},{"date":"2024.11.18","price":"-0.21","value":"-2.07"},{"date":"2024.11.15","price":"-1.45","value":"-2.51"},{"date":"2024.11.14","price":"-1.73","value":"-3.03"},{"date":"2024.11.13","price":"0.51","value":"-1.31"},{"date":"2024.11.12","price":"-1.39","value":"0.55"},{"date":"2024.11.11","price":"0.51","value":"2.28"},{"date":"2024.11.08","price":"-0.53","value":"-0.32"},{"date":"2024.11.07","price":"2.57","value":"2.56"},{"date":"2024.11.06","price":"-0.09","value":"-0.13"},{"date":"2024.11.05","price":"2.32","value":"2.58"}]

上证指数,生物制品行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	欧林生物	17.91%	7.84%	5.6分
2	金迪克	17.71%	4.52%	4.5分
3	迈威生物	16.69%	17.15%	5.7分
4	赛伦生物	10.29%	4.82%	4.7分
5	荣昌生物	8.63%	14.12%	6.0分
6	东宝生物	6.14%	6.33%	5.7分
7	康弘药业	5.38%	3.14%	5.5分
8	未名医药	4.98%	12.79%	5.4分
9	赛升药业	4.95%	5.35%	4.8分
10	博晖创新	4.84%	4.33%	4.9分
11	优宁维	4.52%	3.44%	5.0分
12	昊帆生物	4.01%	7.68%	4.8分
13	君实生物	3.73%	8.89%	5.5分
14	万泰生物	3.18%	4.82%	5.7分
15	艾迪药业	3.03%	3.37%	5.1分
16	卫光生物	2.65%	4.96%	5.7分
17	上海莱士	-0.13%	0.94%	5.5分
18	智飞生物	-0.51%	1.87%	4.6分
19	百克生物	-0.67%	3.54%	5.1分
20	神州细胞	-0.84%	1.02%	4.7分
21	康泰生物	-0.94%	4.34%	5.1分
22	博雅生物	-1.16%	1.94%	5.2分
23	华兰生物	-1.28%	3.28%	5.2分
24	万泽股份	-1.34%	0.26%	5.4分
25	沃森生物	-2.38%	2.29%	4.5分
26	华兰疫苗	-2.43%	3.14%	4.6分
27	安科生物	-3.32%	2.03%	4.8分
28	天坛生物	-3.74%	0.47%	4.8分
29	西藏药业	-4.30%	2.69%	4.9分
30	甘李药业	-5.07%	5.25%	5.5分
31	百奥泰	-5.13%	4.87%	5.7分
32	凯因科技	-5.46%	4.30%	4.8分
33	我武生物	-5.63%	3.22%	4.5分
34	智翔金泰	-6.02%	7.34%	5.2分
35	康华生物	-6.96%	2.81%	5.0分
36	特宝生物	-7.27%	0.23%	4.9分
37	派林生物	-7.60%	2.87%	5.5分
38	三生国健	-8.28%	2.09%	5.4分
39	-	-14.94%	-0.12%	分
40	双成药业	-19.08%	-0.82%	4.3分
41	康辰药业	-19.48%	0.00%	5.3分
42	义翘神州	-73.40%	0.00%	4.9分
43	康希诺	-82.75%	0.00%	4.9分
44	辽宁成大	-1941.27%	0.00%	5.4分
45	长春高新	-6146.96%	1.41%	4.8分
46	成大生物	-	0.65%	5.1分
47	诺诚健华	-	10.39%	5.4分
48	近岸蛋白	-	7.75%	4.0分
49	科兴制药	-	3.91%	5.5分
50	诺唯赞	-	4.41%	5.0分
51	通化东宝	-	0.83%	4.5分
52	百普赛斯	-	7.60%	4.9分
53	四环生物	-	15.53%	5.1分

<上一页 1 2 3 4 5...9 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：4.2基本面打败了2%的股票连续3年业绩增长30%的公司

该公司运营状况不佳，暂时未获得多数机构的显著认同，长期投资价值一般。

个股深一度

潜在高分红能力：弱（50分）

基本面得分最高的股票

[ 截止日期：2024-09-30 ]公司经营

盈利能力：一般，低于行业平均，两项指标的行业排名分别为 38/73 ， 39/73。

[{"date":"2024-09-30","value":"-0.84","vol":"1.38"},{"date":"2024-06-30","value":"-0.41","vol":"0.75"},{"date":"2024-03-31","value":"-0.12","vol":"0.43"},{"date":"2023-12-31","value":"0.59","vol":"1.90"},{"date":"2023-09-30","value":"0.72","vol":"3.06"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
净资产收益率(%)	-0.84	-0.41	-0.12	0.59	0.72
行业(%)	1.38	0.75	0.43	1.90	3.06

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"64.54","vol":"70.59"},{"date":"2024-06-30","value":"63.32","vol":"69.95"},{"date":"2024-03-31","value":"68.28","vol":"70.47"},{"date":"2023-12-31","value":"75.67","vol":"69.93"},{"date":"2023-09-30","value":"82.41","vol":"69.71"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
销售毛利率(%)	64.54	63.32	68.28	75.67	82.41
行业(%)	70.59	69.95	70.47	69.93	69.71

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 40/73 ， 50/73。

[{"date":"2024-09-30","value":"-16.83","vol":"173.80"},{"date":"2024-06-30","value":"-20.13","vol":"17.95"},{"date":"2024-03-31","value":"-39.34","vol":"29.19"},{"date":"2023-12-31","value":"-42.09","vol":"18.84"},{"date":"2023-09-30","value":"-47.93","vol":"15.35"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
营业收入同比增长率(%)	-16.83	-20.13	-39.34	-42.09	-47.93
行业(%)	173.80	17.95	29.19	18.84	15.35

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"-215.00","vol":"-54.20"},{"date":"2024-06-30","value":"-172.05","vol":"-10.79"},{"date":"2024-03-31","value":"-123.61","vol":"-528.49"},{"date":"2023-12-31","value":"-85.84","vol":"-34.06"},{"date":"2023-09-30","value":"-82.38","vol":"272.44"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
净利润同比增长率(%)	-215.00	-172.05	-123.61	-85.84	-82.38
行业(%)	-54.20	-10.79	-528.49	-34.06	272.44

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，两项指标的行业排名分别为 49/73 ， 41/73。

[{"date":"2024-09-30","value":"0.04","vol":"0.22"},{"date":"2024-06-30","value":"0.03","vol":"0.14"},{"date":"2024-03-31","value":"0.01","vol":"0.07"},{"date":"2023-12-31","value":"0.07","vol":"0.33"},{"date":"2023-09-30","value":"0.05","vol":"0.24"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
总资产周转率(次)	0.04	0.03	0.01	0.07	0.05
行业(次)	0.22	0.14	0.07	0.33	0.24

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"0.40","vol":"0.87"},{"date":"2024-06-30","value":"0.27","vol":"0.55"},{"date":"2024-03-31","value":"0.10","vol":"0.26"},{"date":"2023-12-31","value":"0.46","vol":"1.31"},{"date":"2023-09-30","value":"0.22","vol":"0.93"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
存货增长率(次)	0.40	0.27	0.10	0.46	0.22
行业(次)	0.87	0.55	0.26	1.31	0.93

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2024-09-30","value":"-10.65","vol":"-28.68"},{"date":"2024-06-30","value":"46.89","vol":"-36165.87"},{"date":"2024-03-31","value":"28.97","vol":"-43943.29"},{"date":"2023-12-31","value":"41.00","vol":"-170.97"},{"date":"2023-09-30","value":"26.68","vol":"-29016.32"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
现金流量净额/营业收入	-10.65	46.89	28.97	41.00	26.68
行业	-28.68	-36165.87	-43943.29	-170.97	-29016.32

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.82","vol":"2.73"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"1.86","vol":"2.86"},{"date":"2023-09-30","value":"","vol":"0.00"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
资本支出／折旧和摊销	-	0.82	-	1.86	-
行业	0.00	2.73	0.00	2.86	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 51/73 ， 46/73。

[{"date":"2024-09-30","value":"36.07","vol":"7.11"},{"date":"2024-06-30","value":"23.75","vol":"6.99"},{"date":"2024-03-31","value":"36.00","vol":"8.01"},{"date":"2023-12-31","value":"41.30","vol":"7.53"},{"date":"2023-09-30","value":"42.22","vol":"8.24"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
流动比率	36.07	23.75	36.00	41.30	42.22
行业	7.11	6.99	8.01	7.53	8.24

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"13.49","vol":"5.73"},{"date":"2024-06-30","value":"13.86","vol":"5.87"},{"date":"2024-03-31","value":"25.62","vol":"6.87"},{"date":"2023-12-31","value":"31.31","vol":"6.45"},{"date":"2023-09-30","value":"40.03","vol":"7.25"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
速动比率	13.49	13.86	25.62	31.31	40.03
行业	5.73	5.87	6.87	6.45	7.25

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 45/73 ， 45/73。

[{"date":"2024-09-30","value":"4.85","vol":"24.72"},{"date":"2024-06-30","value":"6.32","vol":"24.44"},{"date":"2024-03-31","value":"5.24","vol":"23.84"},{"date":"2023-12-31","value":"4.80","vol":"23.96"},{"date":"2023-09-30","value":"5.02","vol":"22.75"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
资产负债率(%)	4.85	6.32	5.24	4.80	5.02
行业(%)	24.72	24.44	23.84	23.96	22.75

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"0.05","vol":"0.40"},{"date":"2024-06-30","value":"0.07","vol":"0.38"},{"date":"2024-03-31","value":"0.06","vol":"0.36"},{"date":"2023-12-31","value":"0.05","vol":"0.35"},{"date":"2023-09-30","value":"0.05","vol":"0.32"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
产权比率 (%)	0.05	0.07	0.06	0.05	0.05
行业(%)	0.40	0.38	0.36	0.35	0.32

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2024年的收益，请投资者后续关注。

[{"date":"2020","yellowRectValue":"0.83","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"1.49","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.91","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.13","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[近岸蛋白]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]